Search research articles
Contact Us
Filters
Showing results (41-50 of 140) with videos related to
Page
of 14
Sort By:
APL Bioengineering
|
November 3, 2025
Synergy between photonics and biological approaches-A review of combination therapies for cancer theranostics
Jacob P Adams, Luke Pauli, Lin Wang, et al.
Academia Oncology
|
August 5, 2025
Targeted therapy combinations with ipatasertib in multi-cell type 3D tumor spheroid models
Beverly A Teicher, Naoko Takebe, Thomas S Dexheimer, et al.
Leukemia Research
|
February 28, 2007
Phase I and pharmacokinetic study of Triapine, a potent ribonucleotide reductase inhibitor, in adults with advanced hematologic malignancies
Ivana Gojo, Michael L Tidwell, Jacqueline Greer, et al.
Cancer Chemotherapy and Pharmacology
|
March 14, 2024
The effect of liver dysfunction on the pharmacokinetic disposition of belinostat and its five metabolites in patients with advanced cancers
Allison Dunn, Naoko Takebe, Alice Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 18, 2011
Principles and current strategies for targeting autophagy for cancer treatment
Ravi K Amaravadi, Jennifer Lippincott-Schwartz, Xiao-Ming Yin, et al.
Molecular Cancer Therapeutics
|
March 11, 2024
The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs
Ukhyun Jo, Yasuhiro Arakawa, Astrid Zimmermann, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
April 10, 2025
Combinatorial screen with apoptosis pathway targeted agents alrizomadlin, pelcitoclax, and dasminapant in multi-cell type tumor spheroids
Nathan P Coussens, Thomas S Dexheimer, Thomas Silvers, et al.
Cancer Science
|
November 9, 2017
Potential utility of a longitudinal relative dose intensity of molecularly targeted agents in phase 1 dose-finding trials
Akihiro Hirakawa, Kan Yonemori, Fumie Kinoshita, et al.
Clinical Pharmacology and Therapeutics
|
March 31, 2019
A Comparative Study of Longitudinal Toxicities of Cytotoxic Drugs, Molecularly Targeted Agents, Immunomodulatory Drugs, and Cancer Vaccines
Akihiro Hirakawa, Kazuki Sudo, Kan Yonemori, et al.
International Journal of Molecular Sciences
|
May 27, 2026
Real-Time Breath Diagnostics: Linking Molecular Pathways, Measurement Technologies, and Clinical Translation
Velmurugan Thavasi, Nirmal Choradia, Naoko Takebe, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 140) with videos related to
Sort By:
Page
of 14
APL Bioengineering
|
November 3, 2025
Synergy between photonics and biological approaches-A review of combination therapies for cancer theranostics
Jacob P Adams, Luke Pauli, Lin Wang, et al.
Academia Oncology
|
August 5, 2025
Targeted therapy combinations with ipatasertib in multi-cell type 3D tumor spheroid models
Beverly A Teicher, Naoko Takebe, Thomas S Dexheimer, et al.
Leukemia Research
|
February 28, 2007
Phase I and pharmacokinetic study of Triapine, a potent ribonucleotide reductase inhibitor, in adults with advanced hematologic malignancies
Ivana Gojo, Michael L Tidwell, Jacqueline Greer, et al.
Cancer Chemotherapy and Pharmacology
|
March 14, 2024
The effect of liver dysfunction on the pharmacokinetic disposition of belinostat and its five metabolites in patients with advanced cancers
Allison Dunn, Naoko Takebe, Alice Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 18, 2011
Principles and current strategies for targeting autophagy for cancer treatment
Ravi K Amaravadi, Jennifer Lippincott-Schwartz, Xiao-Ming Yin, et al.
Molecular Cancer Therapeutics
|
March 11, 2024
The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs
Ukhyun Jo, Yasuhiro Arakawa, Astrid Zimmermann, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
April 10, 2025
Combinatorial screen with apoptosis pathway targeted agents alrizomadlin, pelcitoclax, and dasminapant in multi-cell type tumor spheroids
Nathan P Coussens, Thomas S Dexheimer, Thomas Silvers, et al.
Cancer Science
|
November 9, 2017
Potential utility of a longitudinal relative dose intensity of molecularly targeted agents in phase 1 dose-finding trials
Akihiro Hirakawa, Kan Yonemori, Fumie Kinoshita, et al.
Clinical Pharmacology and Therapeutics
|
March 31, 2019
A Comparative Study of Longitudinal Toxicities of Cytotoxic Drugs, Molecularly Targeted Agents, Immunomodulatory Drugs, and Cancer Vaccines
Akihiro Hirakawa, Kazuki Sudo, Kan Yonemori, et al.
International Journal of Molecular Sciences
|
May 27, 2026
Real-Time Breath Diagnostics: Linking Molecular Pathways, Measurement Technologies, and Clinical Translation
Velmurugan Thavasi, Nirmal Choradia, Naoko Takebe, et al.
Page
of 14